Search PubMed⌕ Search

Biomedical subjects

Lisa Brown

Publications and source records attributed to Lisa Brown.

4 recordsLinked to original sources
PubMed2006

Feeding skill performance in premature infants during the first year.

BACKGROUND: Little is known about premature infants' feeding skill development and the contribution to it of biologic and environmental conditions. AIMS: Explore the level and variation in feeding skill performance through the first post-term year and examine the contribution to performance of infant neonatal condition and rate of weight gain per day, maternal feeding behavior, and its interaction with neonatal condition. STUDY DESIGN AND SUBJECTS: In this longitudinal, descriptive study, data sources included observed and videotaped in-home feeding for 45 infants <1250 g birth weight and their mothers (age > or =17 years). OUTCOME MEASURE: Feeding skill performance (fdgskill): total number of expected skills at 1, 4, 8, and 12 months, post-term age (PTA). RESULTS: Feeding skill performance varied widely among infants at all four assessments. At 8 and 12 months, fdgskill indicated, for a minority of infants, delay and lack of opportunity to engage in skills associated with new foods and new feeding modalities. Neonatal medical condition contributed significantly to fdgskill at 1 and 4 months, but in the predicted (negative) direction only at four months. Rate of weight gain per day contributed significantly to fdgskill at 1 and 8 months, but in the predicted direction (positive) only at one month. Maternal feeding behavior did not contribute to fdgskill, nor did it interact with infant neonatal conditions to affect fdgskill. CONCLUSIONS: Although infant neonatal medical status and rate of weight gain per day, before or within the span of time between assessments, accounted for some variance in feeding skill performance within the first three assessments (1, 4, and 8 months), much remains to be explained, including neuro- and oral-motor capacities to manage new foods and feeding modalities and opportunities to practice feeding skills during the last half of the first year.

Age Factors↗
PubMed2004

Monitoring the progress of BK virus associated nephropathy in renal transplant recipients.

BACKGROUND: Nephropathy associated with BK virus (BKVAN) has recently emerged as an important cause of allograft failure following renal transplantation. The aim of this study was to evaluate the effectiveness of laboratory markers in the follow-up of patients with BKVAN. METHODS: Serial samples from seven renal transplant recipients with biopsy proven BKVAN were studied. The median follow-up time from diagnosis was 76 weeks. Intervention after the diagnosis of BKVAN included immunosuppression dose reduction, alternative immunosuppressive agents and/or antiviral therapy with cidofovir. Serial urine samples (n = 127) were collected for electron microscopy (EM), decoy cell detection and quantitative urine BK viral load using real-time polymerase chain reaction. Serum BK viral load was also measured serially (n = 72). RESULTS: All patients showed a reduction in serum and urine viral load during the period of follow-up co-incident with the loss of decoy cells and negative urine EM. Urine samples that were negative for decoy cells or polyomavirus by EM had a urine viral load <10(6) copies/ml and a corresponding serum viral load <10(3) copies/ml. In paired serum/urine samples, there was a proportional relationship between serum and urine viral load with each urine viral load approximately 1000-fold higher than the corresponding serum level. Serum and urine viral loads that decreased to <200 and < 10(6) copies/ml, respectively, correlated with histological improvement. CONCLUSION: Negative EM and absence of decoy cells could be used as broad indicators of a response to intervention. However, measurement of BK virus DNA level provided a wider dynamic range and could be a better choice for determining the extent of viral control.

Adult↗
PubMed2003

Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes.

Oral administration of ajulemic acid (AjA), a synthetic nonpsychoactive cannabinoid acid, prevents joint cartilage and bone damage in an experimental model of arthritis in rats. Joint tissue injury in patients with rheumatoid arthritis (RA) is due in part to activation of T lymphocytes in the synovium, and T lymphocytes in synovium of RA patients are resistant to apoptosis. Thus, a potential mechanism whereby AjA prevents joint tissue injury in the animal model might be enhanced apoptosis of T lymphocytes. Apoptosis of human T cells in vitro was assessed by Annexin V expression, caspase-3 activity, DNA fragmentation, and microscopy. AjA induced apoptosis of T cells in a dose- and time-dependent manner. Apoptosis preceded loss of cell viability by trypan blue dye exclusion, confirming that cell loss was due to programmed cell death rather than necrosis. A nontoxic compound such as AjA may be a useful therapeutic agent for patients with diseases such as RA which are characterized by T-cell-driven chronic inflammation and tissue injury.

Annexin A5↗